BASF Acquires Equateq, a Manufacturer of Omega-3 Fatty Acids for Pharmaceuticals

BASF says it has acquired Equateq (Isle of Lewis, U.K.), a global leader in the manufacturing of highly concentrated omega-3 fatty acids. Financial details of the deal were not disclosed. With this acquisition, BASF extends its portfolio of omega-3 products for the pharmaceutical and dietary supplement industries with a new offering of highly concentrated omega-3 fatty acids. Equateq has a production site on the Isle of Lewis with 47 employees. Equateq, with all its employees, will be integrated into the Pharma Ingredients & Services unit, which is part of...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers